Acute effects of cigarillo smoking

Nicotine and Tobacco Research

Volumn 13, Issue 9, 2011, Pages 874-879

  Blank, Melissa D ^a   Nasim, Aashir ^a   Hart Jr , Alton ^b   Eissenberg, Thomas ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE;

ADULT; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CIGARILLO SMOKING; EXPIRED AIR; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SMOKING CESSATION;

EID: 80052698940     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr070     Document Type: Article

References (21)

1. Baker, F., Dye, J. T., Denniston, M. M., & Ainsworth, S. R. (2001). Risk perception and cigar smoking behavior. American Journal of Health Behavior, 25, 106-114. Retrieved from http://www.cinahl.com/cgi-bin/refsvc?jid=182&accno=2001033782.
2. Benowitz, N. L., Porchet, H., Sheiner, L., & Jacob, P. (1988). Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum. Clinical Pharmacology and Therapeutics, 44, 23-28. doi:10.1038/clpt.1988.107.
3. Breland, A. B., Buchhalter, A. R., Evans, S. E., & Eissenberg, T. (2002). Evaluating acute effects of potential reduced-exposure products for smokers: Clinical laboratory methodology. Nicotine & Tobacco Research, 4, S131-S140. doi:10.1080/1462220021000032780.
4. Breland, A. B., Kleykamp, B. A., & Eissenberg, T. (2006). Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine & Tobacco Research, 8, 727-738.
5. Centers for Disease Control and Prevention. (2007). Cigars: Fact sheet, Retrieved from http://www.cdc.gov/tobacco/factsheets/cigars_factsheet.htm.
6. Cox, L. S., Tiffany, S. T., & Christen, A. G. (2001). Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, 7-16. doi:10.1080/14622200020032051.
7. Evans, S. E., Blank, M., Sams, C., Weaver, M. F., & Eissenberg, T. (2006). Transdermal nicotine-induced tobacco abstinence symptoms suppression: Nicotine dose and smokers' gender. Experimental and Clinical Psychopharmacology, 14, 121-135. doi:10.1037/1064-1297.14.2.121.
8. Foulds, J., Stapleton, J., Feyerabend, C., Vesey, C., Jarvis, M., & Russell, M. A. H. (1992). Effect of transdermal nicotine patches on cigarette smoking: A double-blind crossover study. Psychopharmacology, 106, 421-427. Retrieved from http://www.springer.com/biomed/neuroscience/journal/213.
9. Hecht, S. S., & Hoffmann, D. (1989). The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surveys, 8, 273-294. Retrieved from http://www.researchgate.net/journal/0261-2429_Cancer_surveys.
10. Hughes, J. R., & Hatsukami, D. (1986). Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294. Retrieved from http://archpsyc.ama-assn.org.proxy.library.vcu.edu/.
11. Huynh, H., & Feldt, L. S. (1976). Estimation of the box correction for degrees of freedom from sample data in randomized block and split-plot designs. Journal of Educational Statistics, 1, 69-82. doi:10.3102/10769986001001069.
12. Keppel, G. (1991). Design and analysis: A researcher's handbook. Englewood Cliffs, NJ: Prentice Hall.
13. Kure, E. H., Ryberg, D., Hewer, A., Phillips, D. H., Skaug, V., Baera, R., et al. (1996). p53 Mutations in lung tumors: Relationship to gender and lung DNA adduct levels. Carcinogenesis, 17, 2201-2205. doi:10.1093/carcin/17.10.2201.
14. Lakier, J. B. (1992). Smoking and cardiovascular disease. American Journal of Medicine, 93, 8S-12S. Retrieved from http://www.elsevier.com/wps/find/journaldescription.cws_home/525049/description.
15. Maxwell, J. C. (2009). The Maxwell report: Cigar industry in 2008. Richmond, VARetrieved from http://tobaccodocuments.org/pm/1000305800-5814.html.
16. Naidong, W., Shou, W., Chen, Y-L, & Jiang, X. (2001). Novel liquid chromatographic-tandem mass spectrometric methods using silica columns and aqueous-organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids. Journal of Chromatography B, 754, 387-399. doi:10.1016/S0378-4347(01)00021-4.
17. Pickworth, W., Martin, R., Canlas, L., Smith, V. M., Malson, J., & Fabian, L. (2010, June). Toxin delivery after Black & Mild little cigar smoking, Poster presented at the 72nd annual meeting for the College on Problems of Drug Dependence, Scottsdale, AZ.
18. Shanks, T. G., & Burns, D. M. (1998). D. M. Burns, K. M. Cummings & D. Hoffman (Eds.), Cigars: Health effects and trends, Monograph 9 (DHHS Publ No. 98-4302. 105-160). Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health. Retrieved from http://cancercontrol.cancer.gov/tcrb/monographs/9/index.html.
19. U.S. Department of Health and Human Services. (2008). The National Survey on Drug Use and Health, Retrieved from http://www.hhs.gov/.
20. World Health Organization. (2002). The world health report 2002-Reducing risks, promoting healthy life. Quantifying selected major risks to health, chapter 4: Quantifying selected major risks to health. Geneva, Switzerland: Author. Retrieved from http://www.who.int/whr/2002/en/.
21. Zang, E. A., & Wynder, E. L. (1996). Differences in lung cancer risk between men and women: Examination of the evidence. Cancer Research, 56, 772-778. doi:10.1093/jnci/88.3-4.183.